_LIMITED_379234.webp)
Saksham Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.23 Cr
- Satisfied Charges ₹ 3.10 M
- Revenue Growth 1.57%
- Profit Growth 106.36%
- Ebitda 629.51%
- Net Worth 2.92%
- Total Assets 19.88%
About Saksham Pharmaceuticals (India)
Saksham Pharmaceuticals (India) Limited (SPIL) is a Public Limited Indian Non-Government Company incorporated in India on 01 March 2011 and has a history of 13 years and 11 months. Its registered office is in Burari, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.23 Cr. The company has closed loans amounting to ₹3.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ankur Jain, Neelam Jain, and Radhe Shyam serve as directors at the Company.
Company Details
-
Location
Burari, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2011PLC215019
-
Company No.
215019
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 Mar 2011
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Saksham Pharmaceuticals (India) Limited offer?
Saksham Pharmaceuticals (India) Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Anti Infective Drugs & Medicines, Antibacterial Drugs, Dietary Supplements, Nutritional Supplements, Fitness Clubs and Beauty Parlours, Health Club Services, Mineral Supplement.
Who are the key members and board of directors at Saksham Pharmaceuticals (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Jain
|
Director | 01-Mar-2011 | Current |
|
Neelam Jain
|
Director | 01-Mar-2011 | Current |
|
Radhe Shyam
|
Director | 04-Aug-2022 | Current |
Financial Performance of Saksham Pharmaceuticals (India).
Saksham Pharmaceuticals (India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.57% increase. The company also saw a substantial improvement in profitability, with a 106.36% increase in profit. The company's net worth moved up by a moderate rise of 2.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saksham Pharmaceuticals (India)?
In 2023, Saksham Pharmaceuticals (India) had a promoter holding of 60.85% and a public holding of 39.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.23 Cr
₹0.31 Cr
Charges Breakdown by Lending Institutions
- Others : 1.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2019 | Others | ₹1.23 Cr | Open |
| 23 Sep 2014 | Hdfc Bank Limited | ₹3.10 M | Satisfied |
How Many Employees Work at Saksham Pharmaceuticals (India)?
Saksham Pharmaceuticals (India) has a workforce of 6 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saksham Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saksham Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
